These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24529372)

  • 1. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation.
    Ohnishi K; Semi K; Yamamoto T; Shimizu M; Tanaka A; Mitsunaga K; Okita K; Osafune K; Arioka Y; Maeda T; Soejima H; Moriwaki H; Yamanaka S; Woltjen K; Yamada Y
    Cell; 2014 Feb; 156(4):663-77. PubMed ID: 24529372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo.
    Ohnishi K; Semi K; Yamada Y
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):10-5. PubMed ID: 25019993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of genomic imprinting by reprogramming and redifferentiation.
    Kim MJ; Choi HW; Jang HJ; Chung HM; Arauzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2013 Jun; 126(Pt 11):2516-24. PubMed ID: 23525019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of reprogramming technology for cancer research].
    Yagi M; Semi K; Yamada Y
    Nihon Rinsho; 2015 May; 73(5):751-5. PubMed ID: 25985626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
    Yi L; Lu C; Hu W; Sun Y; Levine AJ
    Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system.
    Tsukiyama T; Asano R; Kawaguchi T; Kim N; Yamada M; Minami N; Ohinata Y; Imai H
    Genes Cells; 2011 Jul; 16(7):815-25. PubMed ID: 21658168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs.
    Dong F; Song Z; Zhang J; Lu Y; Song C; Jiang B; Zhang B; Cong P; Sun H; Shi F; Liu H
    Genes Cells; 2013 Jan; 18(1):42-55. PubMed ID: 23231677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ROSA26-iPSC mouse: a conditional, inducible, and exchangeable resource for studying cellular (De)differentiation.
    Haenebalcke L; Goossens S; Dierickx P; Bartunkova S; D'Hont J; Haigh K; Hochepied T; Wirth D; Nagy A; Haigh JJ
    Cell Rep; 2013 Feb; 3(2):335-41. PubMed ID: 23395636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular reprogramming to reset epigenetic signatures.
    Hewitt KJ; Garlick JA
    Mol Aspects Med; 2013; 34(4):841-8. PubMed ID: 22982217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells in medicine and biology.
    Takahashi K; Yamanaka S
    Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPSCs from cancer cells: challenges and opportunities.
    Ramos-Mejia V; Fraga MF; Menendez P
    Trends Mol Med; 2012 May; 18(5):245-7. PubMed ID: 22521522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
    Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
    Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.
    Kleger A; Mahaddalkar PU; Katz SF; Lechel A; Joo JY; Loya K; Lin Q; Hartmann D; Liebau S; Kraus JM; Cantz T; Kestler HA; Zaehres H; Schöler H; Rudolph KL
    Gastroenterology; 2012 Apr; 142(4):907-17. PubMed ID: 22245845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere rejuvenation during nuclear reprogramming.
    Marión RM; Blasco MA
    Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for the derivation of high quality iPSCs in the absence of c-Myc.
    Habib O; Habib G; Choi HW; Hong KS; Do JT; Moon SH; Chung HM
    Exp Cell Res; 2013 Dec; 319(20):3190-200. PubMed ID: 24095950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming can be a transforming experience.
    Hobbs RM; Polo JM
    Cell Stem Cell; 2014 Mar; 14(3):269-71. PubMed ID: 24607400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic pH derived from cancer cells may induce failed reprogramming of normal differentiated cells adjacent tumor cells and turn them into cancer cells.
    Tavakol S
    Med Hypotheses; 2014 Dec; 83(6):668-72. PubMed ID: 25459130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.